Feedback / Questions
AZD5004 - AstraZeneca
https://www.globenewswire.com/news-release/2025/06/18/3101325/0/en/Eccogene-Announces-First-Patient-Dosed-in-Phase-1b-Trial-of-AZD5004-ECC5004-a-Novel-Oral-GLP-1-Receptor-Agonist-in-China.html
Jun 18, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next